SUB01423MIG, SUB01423MIG, Colesevelam-matching placebo film-coated oral tablets (Unit Dose C)., Colesevelam-matching placebo film-coated oral tablets (Unit Dose D)., DISSENTEN 2 mg compresse
F106-CT01
Phase 2 small_molecule active
Quick answer
SUB01423MIG, SUB01423MIG, Colesevelam-matching placebo film-coated oral tablets (Unit Dose C)., Colesevelam-matching placebo film-coated oral tablets (Unit Dose D)., DISSENTEN 2 mg compresse for Bile acid diarrhoea is a Phase 2 program (small_molecule) at Monte Rosa Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Monte Rosa Therapeutics
- Indication
- Bile acid diarrhoea
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active